ClinicalTrials.Veeva

Menu

Assessing Upper Extremity Function in Chronic Stroke Survivors Through Acute Intermittent Hypoxia

Shirley Ryan AbilityLab logo

Shirley Ryan AbilityLab

Status

Not yet enrolling

Conditions

Stroke

Treatments

Other: Acute Intermittent Hypoxia (AIH)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07113457
R21NS130367-01 (U.S. NIH Grant/Contract)
STU00223882

Details and patient eligibility

About

Here we aim to observe effects of acute intermittent hypoxia in persons who have experienced a single stroke. We have previously shown this technique to be safe and effective at increasing strength in persons with disabilities, and here are aiming to determine the mechanism of how the breathing method modulates motor function.

Full description

Here we aim to observe effects of acute intermittent hypoxia in persons who have experienced a single stroke. We have previously shown this technique to be safe and effective at increasing strength in persons with disabilities, and here are aiming to determine the mechanism of how the breathing method modulates motor function.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A first time, unilateral, ischemic, hemispheric stroke, confirmed by MRI
  • Chedoke stage of hand assessment >= 3
  • Ability to open and close affected hand
  • Able to understand and communicate in english
  • Able to independently consent
  • over 6 months post stroke
  • Must have a hemoglobin level above 10g/dl
  • Must have ability to leave research visit with a compainon/group trasportation
  • WOCBP must be comfortable confirming negative pregnancy prior to hypoxia
  • Must not be involved in any other research intervention study testing upper extremities

Exclusion criteria

  • History of prior neurological disorders
  • Brain stem or cerebellar stroke; mean Fazekas score rated on initial fluid-attenuated inversion recovery MRI greater than equal to 3
  • Severe Aphasisa
  • Pre-existing hypoxic pulmonary disease
  • Includes positive Covid-pneumonia diagnosis within 1 year of screening visit
  • Severe hypertension (>160/100)
  • Any ischemic cardiac disease

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Hypoxia
Experimental group
Description:
Participants in this arm will receive approximately 15 bouts of acute intermittent hypoxia. This intervention involves breathing lowered levels of oxygen (similar to being on a tall mountain) for 60 seconds at a time, followed by 60 seconds of room air. Participants will be assessed following the intervention.
Treatment:
Other: Acute Intermittent Hypoxia (AIH)

Trial contacts and locations

0

Loading...

Central trial contact

William Z Rymer, MD, PhD; Alexander J Barry, MS, CCRC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems